Sarah Wang

Sarah frequently advises clients in strategic corporate-commercial and technology transactions in the sectors of life science and TMT, including in-licensing, out-licensing, collaboration, and development agreements in various types of traditional and emerging technology offerings, including software-as-a-service, on-premises software, and technology services and maintenance, and in a broad range of pharmaceutical products and technologies, including biopharmaceutical drugs, immunotherapies, antibody therapeutics, and vaccines.

Before joining Morrison & Foerster, Sarah was an associate in the Shanghai office of an international law firm. She is fluent in English and Mandarin.

Representative Experience

• Represented a prestigious UK school in connection with its development agreement for setting up an international K-12 school with an SOE partner in Yunnan.
• Represented a U.S. leading senior care business in its strategic franchise business restructuring in China, including establishment of a joint venture with an SOE.
• Represented a high-end jewelry retailer in its launch of its flagship store in Shanghai as well as its e-commerce stores in China.
• Represented a UK-based media content provider in its market entry in China and cooperation with major Chinese online content distributors including Baidu.
• Represented a well-known UK technology company in its cross-border service agreement with its SOE partner relating to the provision of a cloud-based service.